DLA Piper advised Commonwealth Laboratories in the sale of its US and Canada diagnostic testing services business to Valeant Pharmaceuticals International.

Commonwealth Laboratories is an independent organization offering tests to diagnose gastrointestinal disorders. Its breakthrough blood test, IBSchek™, is designed to help physicians quickly and reliably diagnose irritable bowel syndrome, which affects nearly 40 million Americans and an estimated 5 million Canadians.
The DLA Piper team representing Commonwealth Laboratories included Jackie Hodes, Jeffrey Musaffi, and Kamal Sleiman (Miami); Erin D'Angelo and Hariqbal Basi (New York); Rebecca McKnight (Austin); Gina Durham, Emily Pence, Lara Compton, and Alina Azizian (San Francisco); Clarissa Bolante (Seattle); Michael Greenberg and Blake Jackson (Silicon Valley); Tom Geraghty (Chicago); Julia Kovacs (Washington, DC); and Lesli Esposito (Philadelphia).